Author  
Place of duty  
Title   Methylxanthines 이 인체위선암 세포주 ( NUGC - 4 ) 에 대한 Cyclophosphamide 의 항암 상승 효과에 관한 연구 ( An Experimental Study on Enhanced Antitumor Effect of Cyclophosphamide by Methylxanthines Human Gastric Cancer Cells ( NUGC - 4 )
Publicationinfo   1992 Jan; 024(04): 469-480.
Key_word  
Full-Text  
Abstract   Methylxanthines(MeX) have been previousely reported to enhance the lethal potential of many DNA damaging agents in rodent and human tumor cells. Recently Pentoxifylline(PENT) and Caffeine, both are MeX, showed the enhancing action of cytotoxicity of alkylating anti-cancer drugs in animal models. The phenomenon attributed to the prevention of DNA reyair. Authors planned this experiment to assess the amplification of the anticancer effect of PENT and Caffeine in combination with one of the alkylating agents, Cyclophosphamide (CTX), for human gastric adenocarcinoma cell line(NUGC-41 The cultured NUGC-4 gastric cancer cells embedded in fibrin clot and were implanted under the renal capsule of the immunocompetent ICR female miceiFibrin clot subrenal capsule assay). After implantation, CTX was given 50 mg/kg, s.c., on day 1 to 5, PENT, 257 mg/kg, s.c., on 2 and 3 day, and in caffeine experiment, caffeine was given 0.175 mg/kg, i.p, on day 2 to 3. For immunosuppression, cyclosporin-A was given 80 mg/kg, s.c., on day 2, 3 and 4 for all experimental mice. Implanted tumor size was measured on day 6 after implantation with stereomicroscope(l mm = 10 omu). The results were summerized as follows: 1) Combination treatment with PENT and CTX for human gastric adenocarcinoma cells (NUGC-4) enhanced the cytotoxicity of CTX with no side effects. PENT alone revealed no anticancer e ffect(p = 0.006). 2) Caffeine with CTX showed also enhancement of anticancer effect of CTX. Caffeine alone disclosed minimal antitumor action, however side effect was prominent with given doaes. 3) Fibrin clot subrenal capsule assay thought to be a simple, fast and effective method to evaluate the efficacy of anti-tumor agent. These results provide the evidence for a novel approach to improve the therapeutic index of CTX and other alkylating agents used for human stomach cancer.
저 자   김재준(Jae Jun Kim),이민혁(Min Hyuk Lee),허경발(Kyung Bal Hur)